Hereditary angioedema (HAE) is a rare genetic disorder that causes episodes of severe swelling throughout your body. It is caused by abnormal immune responses. But unlike allergic swelling, HAE is not ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. There's a lot of latest developments. You ...

The FDA awards Fast Track designation to BW-20805 for hereditary angioedema, a therapy designed to reduce attacks through PKK ...

Hereditary angioedema is a rare genetic disease characterized by severe and unpredictable swelling attacks. NTLA-2002 is an in vivo gene-editing therapy that is based on clustered regularly ...

Possible differential diagnoses for hereditary angioedema (HAE) include acquired angioedema with low C1 inhibitor enzyme (AAE-C1-INH), angiotensin-converting enzyme (ACE) inhibitor-induced angioedema ...

Unlike current treatments on the market for hereditary angioedema, navenibart requires dosing only every 3-6 months.

Staying active is an important component of a healthy lifestyle — it improves heart health, builds strength, and supports mental well-being. For people living with hereditary angioedema (HAE), a rare ...

Hereditary angioedema (HAE) causes severe soft-tissue swelling when C1 inhibitor (C1-INH) dysfunction increases bradykinin, and added inflammation can worsen episodes. Food triggers vary, but studies ...

Data include a concurrent assessment of results collected from PGI and AMRA instruments, insights into clinically meaningful changes in HAE attack symptoms, and support for hierarchical ranking of RAP ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A single dose of ...